Knowledge Center

Poster / Dec 06, 2017

Spray Dried Composite Particles: Formulation and Process Parameters, Effect of two API Concentrations and Stability Assessment

Authors:
  • Maria Palha
  • Raquel Barros
  • Claudia Moura
  • Sara Cardoso
  • Eunice Costa
  • Marcio Temtem
Source:
DDL 2017

In dry powders for inhalation the active pharmaceutical ingredient (API) is typically blended with excipients. However, poor drug delivery uniformity is frequently observed and the addition of a second API further increase the complexity of the formulation. In order to overcome these challenges, the engineering of carrier-free composite particles by spray drying (SD) is a suitable alternative.

Related links

Also in the Knowledge Center

Related Content

Membrane Technology

ËÄÉ«AV has a wide range of membrane capabilities at its disposal including nanofiltration and ultrafiltration.

Page
Read more

Dry Powder Inhalation formulation development

ËÄÉ«AV has considerable inhalation experience that allows us to implement strategies including conventional carrier based, neat (drug-alone) or composite particle formulations.

Page
Read more

Analytical Support

ËÄÉ«AV has experience and capabilities to provide analytical services for Drug Substance, Drug Product and Inhalation Drug Product at all stages of development and commercial phases.

Page
Read more